Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Caribou Biosciences, Inc.CRBU · Entity 6445 | Chief Technology Officer | February 25, 2026 | February 27, 2026 |
| Q32 Bio Inc.FIXX · Entity 5594 | Chief Operating Officer | February 24, 2022 | February 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Caribou Biosciences, Inc.
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,125 |
Reported balance
After 2026-02-25 transaction · row 1
1 source rowRow 1 · 2026-02-25 · Sale · Disposed 6,228 · Balance 73,125 |
Q32 Bio Inc.
Report date February 24, 2022 · Filed February 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.71 · Expires 2032-02-24 | Direct | 28,200 |
Reported balance
After 2022-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-24 · Grant · Acquired 28,200 · Balance 28,200 F1: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,800 |
Reported balance
After 2022-02-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-24 · Grant · Acquired 4,800 · Balance 4,800 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F3: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F3: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 27, 2026 21:01 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | SaleCommon Stock | 6,228 | $1.93 | $12,020.04 |
DisclosureSEC source: 0001754067-26-000004 · wk-form4_1772226070.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,125 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 01:54 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | SaleCommon Stock | 3,147 | $1.96 | $6,168.12 |
DisclosureSEC source: 0001754067-26-000002 · wk-form4_1771984478.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,353 F2 · kind: Reflects the number of shares of common stock that were sold pursuant to the Issuer's mandatory sell-to-cover policy for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. F2 · shares: Reflects the number of shares of common stock that were sold pursuant to the Issuer's mandatory sell-to-cover policy for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:54 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | GrantOption to purchase Common Stock · Derivative | 202,500 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001754067-26-000002 · wk-form4_1771984478.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,500 Underlying: Common Stock · 202,500 shares Expires 2036-02-19 F3 · derivative.exercise_date: 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:54 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001754067-26-000002 · wk-form4_1771984478.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,500 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:18 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | GrantOption to purchase Common Stock · Derivative | 170,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001754067-25-000003 · wk-form4_1740187125.xml · derivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: 25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 01:18 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001754067-25-000003 · wk-form4_1740187125.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 F1 · shares: This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 21:10 UTC | Caribou Biosciences, Inc. CRBU · Entity 6445 | GrantOption to purchase Common Stock · Derivative | 300,000 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001754067-24-000006 · wk-form4_1704834615.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-01-07 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following the one-year cliff), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantRestricted Stock Units · Derivative | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008062 · doc4.xml · derivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 4,800 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantEmployee Stock Option (Right to Buy) · Derivative | 28,200 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0000899243-22-008062 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,200 Underlying: Common Stock · 28,200 shares Expires 2032-02-24 F1 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022. Read SEC document |
| January 05, 2022 Filed Jan 12, 2022 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 1,406 | $3.78 | $5,314.82 |
DisclosureSEC source: 0000899243-22-001747 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,224 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 3,630 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001747 · doc4.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,370 Underlying: Common Stock · 3,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 3,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-001747 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:10 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 54 | $7.70 | $415.80 |
DisclosureSEC source: 0000899243-21-035330 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · shares: Includes 54 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| April 07, 2021 Filed Apr 10, 2021 01:30 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0000899243-21-015515 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after April 12, 2021, so that such option will become fully vested on April 12, 2025. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · derivative · entry 5 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,001 Underlying: Common Stock · 2,000 shares Expires 2027-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was May 30, 2017. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · derivative · entry 4 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 2,000 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 6,232 | $11.16 | $69,562.83 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 2,000 | $2.89 | $5,789.40 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 2,000 | $6.63 | $13,262.80 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,232 shares acquired under Issuer's Employee Stock Purchase Plan on February 26, 2021. Read SEC document |
| March 01, 2021 Filed Sep 8, 2021 20:05 UTC Amendment | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 6,232 | $11.16 | $69,562.83 |
DisclosureSEC source: 0000899243-21-035329 · doc4a.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:24 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantRestricted Stock Units · Derivative | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005460 · doc4.xml · derivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:24 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0000899243-21-005460 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-02-05 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 11:31 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 500 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-004998 · doc4.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 500 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 11:31 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 500 | $13.00 | $6,500.00 |
DisclosureSEC source: 0000899243-21-004998 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 11:31 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 500 | $6.63 | $3,315.70 |
DisclosureSEC source: 0000899243-21-004998 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0000899243-21-004670 · doc4.xml · derivative · entry 5 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,001 Underlying: Common Stock · 2,000 shares Expires 2027-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was May 30, 2017. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-004670 · doc4.xml · derivative · entry 4 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Stock · 2,000 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 4,000 | $12.37 | $49,460.00 |
DisclosureSEC source: 0000899243-21-004670 · doc4.xml · nonDerivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.13 to $12.3680. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 2,000 | $2.89 | $5,789.40 |
DisclosureSEC source: 0000899243-21-004670 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 2,000 | $6.63 | $13,262.80 |
DisclosureSEC source: 0000899243-21-004670 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 500 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-002025 · doc4.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 500 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 500 | $13.00 | $6,500.00 |
DisclosureSEC source: 0000899243-21-002025 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 500 | $6.63 | $3,315.70 |
DisclosureSEC source: 0000899243-21-002025 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0000899243-21-000680 · doc4.xml · derivative · entry 5 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,001 Underlying: Common Stock · 2,000 shares Expires 2027-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was May 30, 2017. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-000680 · doc4.xml · derivative · entry 4 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,500 Underlying: Common Stock · 2,000 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 4,000 | $11.50 | $45,982.80 |
DisclosureSEC source: 0000899243-21-000680 · doc4.xml · nonDerivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $11.19 to $11.65. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 2,000 | $2.89 | $5,789.40 |
DisclosureSEC source: 0000899243-21-000680 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 2,000 | $6.63 | $13,262.80 |
DisclosureSEC source: 0000899243-21-000680 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 21:32 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 1,315 | $13.01 | $17,108.54 |
DisclosureSEC source: 0000899243-20-008885 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018. F2 · shares: Consists of 1,315 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2020. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.60 to $13.48. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantEmployee Stock Option (Right to Buy) · Derivative | 112,000 | $0.00 Strike: $19.92 | $0.00 |
DisclosureSEC source: 0000899243-19-029154 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock · 112,000 shares Expires 2029-12-11 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2020. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 1,166 | $19.94 | $23,251.44 |
DisclosureSEC source: 0000899243-19-023114 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018. F2 · shares: Consists of 1,166 shares acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 22:13 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 1,288 | $20.00 | $25,764.89 |
DisclosureSEC source: 0000899243-19-015650 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018. F2 · shares: Consists of 1,288 shares acquired under the Issuer's Employee Stock Purchase Plan. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.48 to $20.33. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:25 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantEmployee stock option · Derivative | 66,000 | $0.00 Strike: $24.28 | $0.00 |
DisclosureSEC source: 0000899243-18-031344 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 Underlying: Common Stock · 66,000 shares Expires 2028-12-14 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.